Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02909972
Title Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

ALRN-6924 + Cytarabine

ALRN-6924

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST